LAMISIL

Label at a glance#

Contacts and useful links#

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Terbinafine hydrochloride 1%

Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

• cures most athlete’s foot (tinea pedis) between the toes. Effectiveness on the bottom or sides of foot is unknown.
• cures most jock itch (tinea cruris) and ringworm (tinea corporis)
• relieves itching, burning, cracking, and scaling which accompany these conditions

Warnings

WARNINGS SECTION

For external use only

Do Not Use

OTC - DO NOT USE SECTION

• on nails or scalp
• in or near the mouth or the eyes
• for vaginal yeast infections

When using this product

OTC - WHEN USING SECTION

• do not get into eyes. If contact occurs, rinse eyes thoroughly with water.
• do not puncture or incinerate; contents under pressure. Do not expose to heat or store at temperatures above 120 ºF (49 ºC).

Stop use and ask a doctor if

OTC - STOP USE SECTION

too much irritation occurs or gets worse

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.  

Directions

DOSAGE & ADMINISTRATION SECTION

• adults and children 12 years and over:
  • wash the affected area with soap and water and dry completely before applying
  • to open remove clear cap.
  • hold can 4" to 6" from skin.  Press and hold to spray a thin layer over affected area
  • spray affected area once a day (morning or night) for 1 week or as directed by a doctor
  • release to stop spray
  • wipe excess from spray opening after each use
  • return cap to can
    • for athlete’s foot between the toes spray twice a day (morning and night) for 1 week or as directed by a doctor. Wear well-fitting, ventilated shoes. Change shoes and socks at least once daily. Image 1
    • for jock itch and ringworm spray affected area once a day (morning or night) for 1 week or as directed by a doctor
  • wash hands after each use
• children under 12 years: ask a doctor

Other information

STORAGE AND HANDLING SECTION

store at 20 - 25°C (68 - 77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

Ethanol, polyoxyl 20 cetostearyl ether, propylene glycol, purified water

Questions?

OTC - QUESTIONS SECTION

call 1-800-452-0051

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0067-6292-83

TERBINAFINE HYDROCHLORIDE SOLUTION 1% - ANTIFUNGAL

LAMISIL^AT®Spray

Clinically proven to cure most athlete’s foot between the toes

Full prescription strength

Relieves itching, burning, cracking and scaling

 

Net Contents 125 ml (4.2 fl oz)

The only 1 week (twice a day)athlete’s foot spray

DailyMed Billing Units#

DailyMed Socrata Ingredients#

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

• LAMISIL AT Continuous
• TERBINAFINE HYDROCHLORIDE
• TERBINAFINE
• ALCOHOL
• POLYOXYL 20 CETOSTEARYL ETHER
• PROPYLENE GLYCOL
• WATER

NDC Codes#

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 147 matching rows.

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 88 observed states.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.